Funabashi, Japan

Mariko Nasu



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mariko Nasu: Innovator in JAK Inhibitors

Introduction

Mariko Nasu is a prominent inventor based in Funabashi, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of JAK inhibitors. With a total of 2 patents to her name, her work is paving the way for advancements in therapeutic treatments.

Latest Patents

Mariko Nasu's latest patents include "Substituted pyrrolo[3',2′:5,6]pyrido[4,3-d]pyrimidines and JAK inhibitors comprising the same." This patent discloses novel tricyclic pyrimidine and pyridine compounds that exhibit JAK inhibitory activities. The compounds are represented by a specific formula, with detailed definitions provided in the specification. Another significant patent is "Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors." This patent also focuses on novel tricyclic compounds with JAK inhibitory properties, further contributing to the field of medicinal chemistry.

Career Highlights

Mariko Nasu is currently employed at Nissan Chemical Industries Limited, where she continues her research and development efforts. Her work has garnered attention for its potential applications in treating various diseases through innovative chemical compounds.

Collaborations

Mariko collaborates with esteemed colleagues, including Keishi Hayashi and Tsuneo Watanabe. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in the field.

Conclusion

Mariko Nasu is a trailblazer in the development of JAK inhibitors, with her innovative patents reflecting her expertise and dedication. Her contributions to medicinal chemistry are significant and continue to influence the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…